Whole Exome Analysis of NIAAA Clinical Center pATIENTS

Location: Maryland
Posted: Jun 22, 2026
Due: Jul 2, 2026
Agency:
Type of Government: Federal
Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
Solicitation No: 75N98026Q00677
Publication URL: To access bid details, please log in.
Follow
Whole Exome Analysis of NIAAA Clinical Center pATIENTS
Active
Contract Opportunity
Notice ID
75N98026Q00677
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH OLAO
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Presolicitation (Original)
  • Original Published Date: Jun 22, 2026 05:34 pm EDT
  • Original Response Date: Jul 02, 2026 09:00 am EDT
  • Inactive Policy: Manual
  • Original Inactive Date: Jul 03, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside: No Set aside used
  • Product Service Code: 6505 - DRUGS AND BIOLOGICALS
  • NAICS Code:
    • 325414 - Biological Product (except Diagnostic) Manufacturing
  • Place of Performance:
    Bethesda , MD 20892
    USA
Description

The NIAAA Clinical Center patient cohort has been analyzed patients for sequence variant differences, and changes in response to treatment over the course of many years as part of an effort to identify underlying causes of alcohol related disorders. Analysis has previously been performed on over 2000 patients using the AmpliSeq Exome enrichment system and sequenced on the ION sequencing platform because it provides the capability of cost-effective high throughput whole-exome genome-wide analysis. The use of a single enrichment and sequencing platform with consistent information content is essential for analysis of samples screened at different times and it is therefore imperative for analytical integrity that all samples in the study are processed on the same sequencing platform, as each platform has a unique pattern of error


Attachments/Links
Contact Information
Contracting Office Address
  • 6011 EXECUTIVE BLVD., SUITE 503L
  • BETHESDA , MD 20892
  • USA
Primary Point of Contact
Secondary Point of Contact


History
  • Jun 22, 2026 05:34 pm EDTPresolicitation (Original)
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL

See also

...Follow Generic Drug Pathway Curriculum: From ANDA Submission to Global Reliance Active Contract..., ...

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Bid Due: 7/28/2026

...Follow Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S... Intelligence Drug Engineering ...

DEPT OF DEFENSE

Bid Due: 10/18/2028

...Follow Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S... systems. Generative Unconstrained ...

DEPT OF DEFENSE

Bid Due: 10/18/2028

...Follow Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S... systems. Generative Unconstrained ...

DEPT OF DEFENSE

Bid Due: 10/18/2028

* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.